Plandent, UAB - financials and debts

Company age: 31 y. 8 mo.

Update

Lietuvos ir Suomijos Plandent - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2024-01-31
2024
From: 2024-02-01
To: 2025-01-31
2025
From: 2025-02-01
To: 2026-01-31
Financial data
Sales revenue 2,294,411 2,940,581 3,194,268 4,356,489 4,059,939 4,749,132 5,340,744 4,373,233
Profit before tax -5,919 25,354 115,096 127,762 81,324 -64,787 63,543 -16,124
Net profit -6,680 18,388 94,554 105,413 70,699 -69,866 50,168 -17,601
Equity 522,617 541,005 635,559 680,972 751,670 679,893 730,061 712,460
Liabilities 325,709 467,252 567,557 576,185 511,803 897,953 624,521 634,801
Non-current assets 33,850 23,950 59,922 46,532 80,456 58,128 44,922 33,613
Current assets 853,838 1,025,943 1,187,456 1,282,783 1,197,074 1,565,491 1,354,533 1,375,153
Total assets 887,688 1,049,893 1,247,378 1,329,315 1,277,530 1,623,619 1,399,455 1,408,766
Taxes paid
STI taxes - - - - - 771,321 864,875 1,033,574
Social insurance contributions - - - - - 126,132 140,034 138,259
Financial indicators
Revenue change y/y +14.0% +28.2% +8.6% +36.4% -6.8% +17.0% +12.5% -18.1%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -0.8% 1.8% 7.6% 7.9% 5.5% -4.3% 3.6% -1.2%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. -1.3% 3.4% 14.9% 15.5% 9.4% -10.3% 6.9% -2.5%
Profit margin Net profit margin. Shows the overall profitability of the company. -0.3% 0.6% 3.0% 2.4% 1.7% -1.5% 0.9% -0.4%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. -0.3% 0.9% 3.6% 2.9% 2.0% -1.4% 1.2% -0.4%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.6 0.9 0.9 0.8 0.7 1.3 0.9 0.9
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 145,677 185,721 199,642 268,092 223,482 241,481 271,563 238,540

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Lietuvos ir Suomijos Plandent - Social security debts

From To Debt, €
2022-03-16 2022-03-17 1.30
2021-11-16 2021-11-17 32.22
2021-09-16 2021-09-19 63.93

Lietuvos ir Suomijos Plandent - VMI tax arrears

From To Overdue, €
2025-10-03 2025-10-05 72.3
2025-10-02 2025-10-02 72.08

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Plandent, UAB, a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods, generated €4.37M in revenue in 2025. This was below the €5.34M recorded in 2024, after €4.75M in 2023, showing a decline in the latest year and a softer two-year trend. The company moved from a net profit of €50.2K in 2024 to a net loss of €17.6K in 2025, following a loss of €69.9K in 2023. Profitability remained weak in 2025 with a net margin of -0.4%. Balance sheet values were broadly stable, with total assets of €1.41M, equity of €712.5K and liabilities of €634.8K. The equity ratio stood at 50.6% and debt-to-equity at 0.89, indicating a balanced capital structure. Asset turnover was 3.10x, while return on equity was -2.5% and return on assets -1.2%. Revenue per employee was €243.0K and profit per employee was -€978, pointing to solid sales productivity but limited earnings conversion in the latest financial year.